Histology
Munich, 20 February 2017 -- microDimensions launches a new version of its high precision whole slide alignment software Slidematch. With the new version users can align digital whole slide images from consecutive sections in brightfield and...
‘Crosswalk’ Re-Launched to Make it Easier to Bridge the Gap Between...
- Advocacy
- Anatomic Pathology
- Clinical Laboratories
- Clinical Pathology
- Conferences
- Current Affairs
- Device Manufacturers
- Digital Pathology News
- Education
- Electronic Medical Records
- General Healthcare News
- Genetics
- Histology
- Image Analysis
- Informatics
- Laboratory Informatics
- Laboratory Information Systems
- Laboratory Management & Operations
- Liquid Biopsy
- Medical Research
- Molecular Pathology
- Pathology News
- TeleHealth
- Vendor products
- Web/Tech
- Whole slide
Inspirata has just released new mobile and Web-based versions of “Crosswalk Insight: Oncology™,” a knowledge visualization platform that enables users to easily navigate through tumor images and the associated molecular pathways, targeted...
Will Not Using Image Analysis in Pathology be Perceived as Irrespon...
- Advocacy
- Anatomic Pathology
- Blogs
- Clinical Laboratories
- Clinical Pathology
- Current Affairs
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- General Healthcare News
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Compliance
- Laboratory Informatics
- Laboratory Management & Operations
- Medical Research
- Molecular Pathology
- Pathology News
- Science
- TeleHealth
- Web/Tech
- Whole slide
Originally published by Simon Häger, Product Manager Sectra Digital Pathology Solution at Sectra.com. It is hard to argue with any of the points raised here by Simon. No doubt image analysis will enable what we do to do it better. More...
Save your spot to learn more about the effects of reimbursement changes in the US on the anatomic pathology market and in your laboratory You are invited to our next complimentary webinar – January 24, 2017 Understanding Reimbursement...
This story from GE Reports was originally published during RSNA last year to help promote their new mammography equipment and referenced the good work being done at Gustave Roussy Cancer Center in a southern suburb of Paris. But same day...
In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive...
